advanced search

Welcome: Guest

log in

Endovasc, Inc. Product Pipeline Analysis

Publication Date August 2008
Publisher Global Markets Direct
Product Type Report
Pages 25
ISBN Number not applicable
Product Code GMD04655
Price

£490.00
approximately: $749 | €546

PDFBuy Now
Order above formats by FAXOrder by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Endovasc, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.

Reasons to buy

  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

  • 1 List of Tables
    • 1.2 List of Figures
  • 2 Company Snapshot
    • 2.1 Key Information
    • 2.2 Company Overview
    • 2.3 Financial Performance
    • 2.4 Industry Outlook Cardiovascular Devices
  • 3 Business Description
    • 3.1 Business Overview
    • 3.2 Major Products and Services
      • 3.2.1 Overview
  • 4 History
  • 5 Competitors
  • 6 Key Employees
  • 7 Key Employee Biographies
  • 8 Locations And Subsidiaries
    • 8.1 Head Office
  • 9 Recent Developments
    • 9.1 Strategy And Business Planning
      • 9.1.1 Jun 20, 2007: Endovasc Forms New Subsidiary
    • 9.2 Financial Announcements
      • 9.2.1 Nov 22, 2007: Endovasc Declares Quarterly Results
    • 9.3 Corporate Communications
      • 9.3.1 Apr 27, 2007: Endovasc VP - Business Development Resigns
      • 9.3.2 Jan 10, 2007: Endovasc Appoints CFO
      • 9.3.3 Dec 13, 2006: Endovasc Appoints New Board Member
      • 9.3.4 Nov 28, 2006: Endovasc Appoints New Board Member
    • 9.4 Product News
      • 9.4.1 Oct 18, 2004: New Endovasc Subsidary To Showcase ProStent technology
  • 10 Endovasc, Inc. Pipeline Products
    • 10.1 Endovasc, Inc. Product Pipeline Analysis
      • 10.1.1 Endovasc, Inc. Pipeline Products By Equipment Type
      • 10.1.2 Endovasc, Inc. Pipeline Products By Development Stage
      • 10.1.3 Endovasc, Inc. Pipeline Products By Therapy Area
      • 10.1.4 Endovasc, Inc. Pipeline Products By News Summary
    • 10.2 PROStent
      • 10.2.1 Product Description
      • 10.2.2 Product Status
      • 10.2.3 Product Milestone
    • 10.3 Biodegradable Vascular Stents
      • 10.3.1 Product Description
      • 10.3.2 Product Status
    • 10.4 Biodegradable Ureteral Stent
      • 10.4.1 Product Description
      • 10.4.2 Product Status
    • 10.5 Biodegradable Prostatic Stent
      • 10.5.1 Product Description
      • 10.5.2 Product Status
  • 11 Appendix
    • 11.1 Methodology
      • 11.1.1 Coverage
      • 11.1.2 Secondary Research
      • 11.1.3 Primary Research
      • 11.1.4 Expert Panel Validation
    • 11.2 Contact Us
    • 11.3 About Global Markets Direct
    • 11.4 Disclaimer
  • 1 List of Tables
    • Table 1: Endovasc, Inc.,Key Facts
    • Table 2: Endovasc, Inc., Key Employees,
    • Table 3: Endovasc, Inc. Pipeline Products by Equipment Type
    • Table 4: Endovasc, Inc. Pipeline Products By Development Stage
    • Table 5: Endovasc, Inc. Pipeline Products By Therapy Area
    • Table 6: Endovasc, Inc. Pipeline Products By News Summaries
    • 1.2 List of Figures
    • Figure 1: Endovasc, Inc. Pipeline Products By Development Stage
    • Figure 2: Global Markets Direct Methodology